Analysts Race to Raise Targets as DDOG Sells Off Into Earnings

Datadog heads into its June 15 earnings call with a striking disconnect: a wave of analyst upgrades landing the same week the stock fell 15.5%.

The analyst activity is hard to ignore. Virtually every firm that published this week raised its price target — and none cut. Evercore ISI lifted to $265 from $225, Barclays moved to $260 from $215, Wedbush raised to $260 from $220, and BofA Securities bumped its target to $280 from $260 just days earlier. Piper Sandler went to $275, CIBC to $280. Targets across the group now cluster in the $250–$280 range, all carrying Outperform or Buy ratings. The consensus mean price target of $230.55 is already above the current close of $227.34, meaning the stock has essentially sold off into fair value as the Street sees it — a setup that tends to put more pressure on the earnings print itself to close the gap.

The bull case centers on Datadog's multi-product platform, with Bits AI SRE and observability pipelines cited as differentiators against a field that includes a now-absorbed Splunk and a still-formidable CrowdStrike. Bears point to margin expansion risks in a commoditizing market, potential pricing pressure, and the reality that DDOG's valuation multiples remain elevated at 87x trailing earnings and nearly 65x EV/EBITDA — both still above the broader software peer set even after this week's compression. Factor scores reinforce the growth narrative: the 12-month forward EPS growth rank is in the 94th percentile and the 90-day EPS momentum rank is at 79. EPS surprise, however, ranks only in the 28th percentile — a useful caveat going into a print.

The borrow market tells an uncrowded story. Availability in the lending pool is exceptionally loose at roughly 3,100% — meaning there are far more shares available to borrow than shares currently short. Cost to borrow has eased to 0.35%, down from around 0.47% a month ago, and short interest has dipped over the week to 4.6% of the free float after running closer to 4.9% in late May. The ORTEX short score has edged lower to 37.3, its weakest reading in the past two weeks. None of this describes a name with meaningful short-seller conviction — the borrow conditions and the score both point to a positioning environment that is distinctly relaxed.

Options offer a mild counterpoint. The put/call ratio climbed to 0.90 on Tuesday, roughly one standard deviation above its 20-day average of 0.86. That's a nudge toward defensiveness, not a pronounced hedge — the 52-week high on the PCR is 2.30, so current levels are far from stressed. The modest uptick in put demand likely reflects straightforward pre-earnings caution rather than directional conviction. The stock's earnings history adds weight to that caution: the last reported print produced a one-day move of +39% and a five-day move of +41%, making this a genuinely high-volatility event by any measure.

Peer context rounds out the picture. CRWD fell 16.1% on the week — steeper than DDOG's 15.5% — while PANW dropped 12.3% and DT gave back 9.3%. The sector-wide selloff suggests the move in DDOG is more macro and sector rotation than a stock-specific re-rating, which may partly explain why the Street's reaction was to raise targets rather than trim them.

The June 15 report is the obvious next focal point — specifically whether revenue guidance can justify the premium embedded in the $250-plus targets that analysts have just reinstated.